BOM Capital (previously known as Brabant Development Society Participations) has taken part in a €45m round of funding for Amsterdam-based biotechnology group Protix Biosystems.
Standout Capital holds 55% of the shares, while former owners retain a 45% stake in the company
Deal marks a partial sale for the US-based private equity house after a three-year holding period
Postgraduate student loans company also secured a $200m debt facility as part of the deal
Fundraising figures from unquote" data point towards a record year for UK-based managers, following the post-crisis peak reached in 2016